
The statement put Rajji in the crosshairs of Hezbollah supporters, with several prominent figures releasing statements condemning the Foreign Minister and his statement during the interview.
Youssef Rajji, the Minister of Foreign Affairs of Lebanon, said that "so long as Hezbollah is not completely disarmed, Israel has the right to continue its attacks," in an interview with Sky News, N12 reported on Wednesday.
The statement put Rajji in the crosshairs of Hezbollah supporters, with several prominent figures releasing statements condemning the Foreign Minister and his statement during the interview.
Lebanese pro-Hezbollah newspaper Al Akhbar published a piece describing Rajji as the "speaker of the enemy in the government," and called for the Lebanese Prime Minister and President to take action against him.
"He did not hesitate to turn the Foreign Ministry into a mobile mouthpiece for distraction, using diplomatic hybrid language which addresses the other side using rhetoric and not political speech," Al Akhbar said. "There is no point in warning him, or directing his attention away, because the whole Foreign Ministry is no longer Lebanese in its rhetoric or role."
Hezbollah member of Parliament stands against Rajji
Ali Ammar, a Hezbollah member of the Lebanese Parliament, also denounced Rajji, calling him "a resonant political, national, and moral failure."
Ammar also urged the Prime Minister and President to take a stand against Rajji's words.
Agricultural drones are taking off globally, saving farmers time and money
The Most recent Microsoft Surface Star PC: Ideal for Top of the line Planning and Gaming Needs
CMA Awards 2025: Full list of nominations, from Entertainer of the Year to Album of the Year
Strength training is crucial after menopause. How to make the most of your workouts
Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
My skin feels drier, my lips thinner and my makeup heavier. How do I adjust my routine for aging skin?
See a half-lit moon shine among the stars of Aquarius on Nov. 27
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Must-See Attractions in Washington, D.C.












